Inventor

FELGNER PHILIP L

US38 patents

⚠️ This page may combine multiple inventors who share the name “FELGNER PHILIP L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FELGNER PHILIP L

VICAL INC

Induction of a protective immune response in a mammal by injecting a DNA sequence

Delivery of exogenous DNA sequences in a mammal

Methods of delivering a physiologically active polypeptide to a mammal

Induction of a protective immune response in a mammal by injecting a DNA sequence

Expression of exogenous polynucleotide sequences cardiac muscle of a mammal

Cationic lipids for intracellular delivery of biologically active molecules

Cationic lipids for intracellular delivery of biologically active molecules

Methods for treating cancer using cytokine-expressing polynucleotides

Generation of an immune response to a pathogen

Lipid-mediated polynucleotide administration to reduce likelihood of subject&#39;s becoming infected

Expression of exogenous polynucleotide sequences in a vertebrate

Stimulating vascular growth by administration of DNA sequences encoding VEGF

Methods for treating cancer using interferon-ω-expressing polynucleotides

Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human

SYNTEX INC

N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor

N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor

N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor

N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor

N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor

N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor

N-[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N,-tetrasubstituted ammonium lipids and uses therefor

Vaccine adjuvant

N-[ω, (ω-1)-dialkyloxy]- and N-[ω, (ω-1)-dialkenyloxy]-alk-1-yl-N, N, N-tetrasubstituted ammonium lipids and uses therefor

C-reactive protein fragment with immunomodulatory activity

Liquid single reagent for assays involving confining gels

GENE THERAPY SYSTEMS INC

Rapid and enzymeless cloning of nucleic acid fragments

Amphiphilic polyamine compounds

Amphiphilic polyamide compounds

Protein arrays and methods and systems for producing the same

WISCONSIN ALUMNI RES FOUND

Generation of antibodies through lipid mediated DNA delivery

Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response

GENE THERAPY SYSTEMS

Chemical modification of DNA using peptide nucleic acid conjugates

Method for generating transcriptionally active DNA fragments

BARBOUR ALAN G

Borrelia diagnostics and screening methods

Borrelia diagnostics and screening methods

(unassigned)

N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor

JOLLA INST ALLERGY IMMUNOLOG

H3L envelope protein immunization methods and H3L envelope passive protection methods

ISIS PHARMACEUTICALS INC

Chemical modification of DNA using peptide nucleic acid conjugates

Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected